Jakubowski, Ann

Selected publications

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. Journal of Clinical Investigation. 2020 Academic Article GET IT
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 2020 Academic Article GET IT
Drugs as a Frequent Cause of Acute Rash in Patients after CD34⁺-Selected Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019 Academic Article GET IT
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations. British Journal of Haematology. 2019 Academic Article GET IT
Times cited: 4
Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 1
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults. Blood advances. 2019 Academic Article GET IT
Times cited: 3
Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes. Biology of Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 1
Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34⁺ selected graft. Bone Marrow Transplantation. 2019 Article GET IT
Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation–a single institution pilot study. Leukemia and Lymphoma. 2019 Letter GET IT
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 1
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone Marrow Transplantation. 2019 Academic Article GET IT
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience. Transplant Infectious Disease. 2019 Academic Article GET IT
Times cited: 3
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34 ⁺ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 1
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC. Journal of Hematology and Oncology. 2018 Academic Article GET IT
Times cited: 4
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Science Translational Medicine. 2018 Academic Article GET IT
Times cited: 45
Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience. Bone Marrow Transplantation. 2018 Information Resource GET IT
Times cited: 9
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34⁺Selected and Unmodified Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 2
CD34⁺Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 4
Cytomegalovirus resistance in CD34⁺-selected hematopoietic cell transplant recipients. Transplant Infectious Disease. 2018 Academic Article GET IT
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 2
Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients. Transplant Infectious Disease. 2018 Academic Article GET IT
Times cited: 2
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center. Bone Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 3
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leukemia and Lymphoma. 2017 Academic Article GET IT
Times cited: 21
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 7
Ex Vivo CD34⁺–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 9
Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants. Bone Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 4
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 1
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 4
Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34⁺ Selected Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 14
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 6
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34⁺ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 11
Impact of Toxicity on Survival for Older Adult Patients after CD34⁺Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 5
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer. 2017 Academic Article GET IT
Times cited: 24
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 7
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 5
A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation. Bone Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 1
Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS. Bone Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 3
Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leukemia and Lymphoma. 2016 Academic Article GET IT
Times cited: 6
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 43
Cytomegalovirus Infection after CD34⁺-Selected Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 13
Adenovirus Viremia in Adult CD34+ Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact. Biology of Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 12
Transmission of clostridium difficile during hospitalization for allogeneic stem cell transplant. Infection Control and Hospital Epidemiology. 2016 Academic Article GET IT
Times cited: 14
Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin. Clinical Infectious Diseases. 2015 Academic Article GET IT
Times cited: 22
Prognostic importance of pretransplant functional capacity after allogeneic hematopoietic cell transplantation. Oncologist. 2015 Academic Article GET IT
Times cited: 10
Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation. Leukemia Research. 2015 Academic Article GET IT
Times cited: 5
Prospective assessment of white matter integrity in adult stem cell transplant recipients. Brain Imaging and Behavior. 2015 Academic Article GET IT
Times cited: 8
Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 15
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse. Biology of Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 28
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 22
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 19
Histopathologic features of cutaneous acute graft-versus-host disease in T-cell-depleted peripheral blood stem cell transplant recipients. American Journal of Dermatopathology. 2015 Academic Article GET IT
Times cited: 4
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leukemia and Lymphoma. 2015 Academic Article GET IT
Times cited: 11
A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients. Biology of Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 20
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 2014 Academic Article GET IT
Times cited: 57
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies. Leukemia and Lymphoma. 2014 Academic Article GET IT
Times cited: 4
Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival. Biology of Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 25
Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplantation. 2014 Review GET IT
Times cited: 48
Clostridium Difficile infection after allogeneic hematopoietic stem cell transplant: Strain diversity and outcomes associated with NAP1/027. Biology of Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 24
Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study. Journal of Infection. 2014 Academic Article GET IT
Times cited: 11
Relationship of BK Polyoma Virus (BKV) in the Urine with Hemorrhagic Cystitis and Renal Function in Recipients of T Cell-Depleted Peripheral Blood and Cord Blood Stem Cell Transplantations. Biology of Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 9
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood. 2013 Academic Article GET IT
Times cited: 62
Prevalence of hematopoietic cell transplant survivors in the United States. Biology of Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 92
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission. Biology of Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 58
Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit-to-Recipient HLA Match. Biology of Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 47
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. Biology of Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 40
Adenovirus Viremia and Disease: Comparison of T Cell-Depleted and Conventional Hematopoietic Stem Cell Transplantation Recipients from a Single Institution. Biology of Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 36
T Cell-Depleted Stem Cell Transplantation for Adults with High-Risk Acute Lymphoblastic Leukemia: Long-Term Survival for Patients in First Complete Remission with a Decreased Risk of Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 28
A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging and Behavior. 2013 Academic Article GET IT
Times cited: 23
Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 35
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 2012 Academic Article GET IT
Times cited: 89
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease. Journal of Neuro-Oncology. 2012 Academic Article GET IT
Times cited: 30
Disseminated mycobacterium marinum infection in a hematopoietic stem cell transplant recipient. Transplant Infectious Disease. 2012 Academic Article GET IT
Times cited: 7
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant. Leukemia and Lymphoma. 2012 Academic Article GET IT
Times cited: 28
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation. Blood. 2012 Academic Article GET IT
Times cited: 223
Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center forInternational Blood and Marrow Transplant Research Study. Biology of Blood and Marrow Transplantation. 2012 Academic Article GET IT
Times cited: 50
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 57
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biology of Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 57
Retrospective Outcome Data for Hematopoietic Stem Cell Transplantation in Patients with Concurrent Coronary Artery Disease. Biology of Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 5
Pregnancy after Hematopoietic Cell Transplantation: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biology of Blood and Marrow Transplantation. 2011 Review GET IT
Times cited: 56
Recurrent neurotropic chloroma: Report of a case and review of the literature. Advances in Hematology. 2011 Academic Article GET IT
Times cited: 16
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Journal of Clinical Oncology. 2010 Review GET IT
Times cited: 202
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010 Review GET IT
Times cited: 157
The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients. Biology of Blood and Marrow Transplantation. 2010 Academic Article GET IT
Times cited: 87
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone Marrow Transplantation. 2010 Academic Article GET IT
Times cited: 15
Chronic Kidney Disease, Thrombotic Microangiopathy, and Hypertension Following T Cell-Depleted Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2010 Academic Article GET IT
Times cited: 45
Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2010 Academic Article GET IT
Times cited: 32
Stem cell transplantation. 2010 Chapter GET IT
Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias. Journal of Hematology and Oncology. 2009 Academic Article GET IT
Times cited: 8
Thalidomide induced acute worsening of Parkinson's disease. Movement Disorders. 2009 Information Resource GET IT
Times cited: 6
Risk Factors for Late Staphylococcus Aureus Bacteremia after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Institution, Nested Case-Controlled Study. Biology of Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 20
In reply. Journal of Clinical Oncology. 2008 Information Resource GET IT
Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT). Biology of Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 43
Unrelated donor transplants in adults with philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 2008 Academic Article GET IT
Times cited: 54
Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transplant Infectious Disease. 2008 Academic Article GET IT
Times cited: 21
Guideline summary: Use of epoetin and darbepoetin in patients with cancer - 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice guideline update. Journal of Oncology Practice. 2008 Academic Article GET IT
Times cited: 1
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice guideline update. Journal of Clinical Oncology. 2008 Review GET IT
Times cited: 242
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood. 2008 Review GET IT
Times cited: 134
T cell-depleted stem-cell transplantation for adults with hematologic malignancies: Sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood. 2007 Academic Article GET IT
Times cited: 83
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 2007 Academic Article GET IT
Times cited: 34
Fludarabine-Based Conditioning Secures Engraftment of Second Hematopoietic Stem Cell Allografts (HSCT) in the Treatment of Initial Graft Failure. Biology of Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 37
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease. Bone Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 57
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: High mortality in the era of cidofovir. Transplant Infectious Disease. 2007 Academic Article GET IT
Times cited: 94
Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 22
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood. 2006 Academic Article GET IT
Times cited: 40
Novel approaches in allogeneic stem cell transplantation. Current Oncology Reports. 2006 Article GET IT
Times cited: 2
Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: An approach in development. Bone Marrow Transplantation. 2006 Review GET IT
Times cited: 87
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer. Drugs & aging.. 2005 Academic Article GET IT
Times cited: 22
Developing a cancer-specific geriatric assessment: A feasibility study. Cancer. 2005 Academic Article GET IT
Times cited: 369
Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant [6]. Bone Marrow Transplantation. 2005 Article GET IT
Times cited: 15
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Drugs & aging.. 2005 Article GET IT
Times cited: 10
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Research and Treatment. 2005 Academic Article GET IT
Times cited: 40
Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transplant Infectious Disease. 2005 Academic Article GET IT
Times cited: 101
Imaging therapeutic response in human bone marrow using rapid whole-body MRI. Magnetic Resonance in Medicine. 2004 Academic Article GET IT
Times cited: 60
Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: A single-center observational cohort study. Clinical Infectious Diseases. 2004 Academic Article GET IT
Times cited: 28
Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2004 Academic Article GET IT
Times cited: 23
High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2003 Academic Article GET IT
Times cited: 62
Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. 2002 Review GET IT
Times cited: 189
Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Journal of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 385
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clinical Infectious Diseases. 2002 Academic Article GET IT
Times cited: 74
Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: Findings in the era of serum cytomegalovirus antigen surveillance. Chest. 2001 Academic Article GET IT
Times cited: 41
Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host disease. Bone Marrow Transplantation. 2001 Academic Article GET IT
Times cited: 2
Bone marrow segmentation in leukemia using diffusion and T2 weighted echo planar magnetic resonance imaging. NMR in Biomedicine. 2000 Academic Article GET IT
Times cited: 31
Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood. 1999 Academic Article GET IT
Times cited: 366
Quantitative assessment of bone marrow hematopoiesis using parametric magnetic resonance imaging. Magnetic Resonance in Medicine. 1998 Academic Article GET IT
Times cited: 19
Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIHW 3T3 cells. Growth Factors. 1997 Academic Article GET IT
Times cited: 34
Comparative activity of melarsoprol and arsenic trioxide in chronic B- cell leukemia lines. Blood. 1997 Academic Article GET IT
Times cited: 105
Noninvasive evaluation of the bone marrow. Journal of Nuclear Medicine. 1996 Article GET IT
Spatial mapping of the percentage cellularity in human bone marrow using magnetic resonance imaging. Medical Physics. 1996 Academic Article GET IT
Times cited: 14
Granulocyte colony stimulating factor (G-CSF): Biology and clinical status. Cancer Biotherapy and Radiopharmaceuticals. 1996 Review GET IT
Times cited: 5
Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia. American Journal of Hematology. 1996 Academic Article GET IT
Times cited: 9
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma. Clinical Cancer Research. 1996 Academic Article GET IT
Times cited: 15
A pilot study of the biologic and therapeutic effects of granulocyte colonystimulating factor (filgrastim) in patients with acute myelogenous leukemia. Leukemia. 1995 Academic Article GET IT
Times cited: 4
9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood. 1995 Academic Article GET IT
Times cited: 82
Treatment of chronic neutropenia associated with large granular lymphocytosis with cyclosporine a and filgrastim. American Journal of Hematology. 1995 Academic Article GET IT
Times cited: 13
Phase I trial of intravenous and intraperitoneal administration of granulocyte-macrophage colony-stimulting factor. Journal of Immunotherapy with Emphasis on Tumor Immunology. 1994 Academic Article GET IT
Times cited: 9
Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers. Magnetic Resonance in Medicine. 1993 Academic Article GET IT
Times cited: 28
Interleukin-1 modulation of cytokine receptors on human neutrophils: In vitro and in vivo studies. Blood. 1993 Academic Article GET IT
Times cited: 15
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993 Academic Article GET IT
Times cited: 345
Interleukin-1: Biological effects in human hematopoiesis. Leukemia and Lymphoma. 1993 Review GET IT
Times cited: 31
Use of CSF-G in Acute Nonlymphocytic Leukemia. Journal of Hematotherapy and Stem Cell Research. 1993 Academic Article GET IT
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood. 1992 Academic Article GET IT
Times cited: 408
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New England Journal of Medicine. 1991 Academic Article GET IT
Times cited: 1130
A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood. 1991 Academic Article GET IT
Times cited: 116
In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy. Magnetic Resonance in Medicine. 1991 Academic Article GET IT
Times cited: 61
Novel retinoic acid receptor-α transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. Journal of the National Cancer Institute. 1990 Academic Article GET IT
Times cited: 64
Biological effects and clinical applications of human colony-stimulating factors. Cancer chemotherapy and biological response modifiers. 1990 Review GET IT
Times cited: 4
Hematopoietic growth factors: biology and clinical application. Journal of the National Cancer Institute - Monographs. 1990 Review GET IT
Times cited: 20
Colony-stimulating factors and neutrophil migration. Annals of Internal Medicine. 1989 Article GET IT
Times cited: 13
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. New England Journal of Medicine. 1989 Academic Article GET IT
Times cited: 129
Granulocyte colony-stimulating factor: Preclinical and clinical studies. Hematology/Oncology Clinics of North America. 1989 Review GET IT
Times cited: 19
Phase I trial intramuscularly administered tumor necrosis factor in patients with advanced cancer. Journal of Clinical Oncology. 1989 Academic Article GET IT
Times cited: 59
Recombinant human granulocyte colony stimulating factors: Therapeutic application in the prevention of chemotherapy-induced neutropenia. Behring Institut Mitteilungen. 1988 Academic Article GET IT
Times cited: 2
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. New England Journal of Medicine. 1988 Academic Article GET IT
Times cited: 770
Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5‐fluorouracil. Cancer. 1988 Academic Article GET IT
Times cited: 30
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. Journal of Clinical Investigation. 1988 Academic Article GET IT
Times cited: 185

VIVO Weill Cornell Medical College

Ann Jakubowski Professor of Medicine

Publications

Selected publications

Background

Education and Training

Phone

Publications

Selected publications

Background

Education and Training